Who is sponsoring NCT02826226?

NCT02826226 is sponsored by Universitätsmedizin Mannheim.

What drugs are being tested in NCT02826226?

Interventions in NCT02826226: multiple-breath-washout test, Bronchodilator Agents.

What condition does NCT02826226 study?

NCT02826226 studies Obstructive Ventilation Disorders.

Is NCT02826226 still recruiting?

NCT02826226 is currently completed. Last updated 30 December 2018.

Last reviewed 2018-12-30 · How we verify

NCT02826226

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Bronchodilatator Testing on Multiple-breath-washout (MBW) Derived Lung Function Parameters

Completed Last updated 30 December 2018

What this trial tests

trial testing multiple-breath-washout test in Obstructive Ventilation Disorders in 145 participants. Completed in 1 December 2018.

Timeline

1 May 2016

Primary endpoint
1 December 2018

1 December 2018

Quick facts

Lead sponsor	Universitätsmedizin Mannheim
Status	Completed
Study type	OBSERVATIONAL
Enrollment	145
Start date	1 May 2016
Primary completion	1 December 2018
Estimated completion	1 December 2018
Sites	1 location across Germany

Drugs / interventions tested

multiple-breath-washout test
Bronchodilator Agents — full drug profile →

Conditions studied

Obstructive Ventilation Disorders — all drugs for Obstructive Ventilation Disorders →

Sponsor

Universitätsmedizin Mannheim — full company profile →

Who can join

18 and older, any sex, with Obstructive Ventilation Disorders. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

change of lung clearance index (LCI) as determined by multiple breath washout
Time frame: 60 minutes

Sponsor's own description

The investigators aim to evaluate the effect of bronchodilatator testing on multiple-breath-washout derived lung function parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Universitätsmedizin Mannheim trials

Trials by the same sponsor.

NCT06416319 — Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct) · NA · recruiting
NCT04534998 — Robotic-assisted vs. Open Partial Nephrectomy · Phase 2 · unknown
NCT05575856 — Cardiogenic Shock Registry Mannheim · unknown
NCT04146701 — Metabolomics and Microbiomics in Cardiovascular Diseases · unknown
NCT04533633 — German Epicardial Collateral CTO Registry · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02826226 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitätsmedizin Mannheim
Last refreshed: 30 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02826226.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing